Traitement en cours

Veuillez attendre...

Paramétrages

Paramétrages

Aller à Demande

1. WO2020161242 - DOSAGE DE COLLAGÈNE DE TYPE XXIII


Avertissement La version image (PDF) disponible dans PATENTSCOPE est la version officielle. Cette version HTML en ligne est fournie pour aider les utilisateurs. Malgré le grand soin apporté à la compilation pour assurer une représentation précise et exacte des données figurant sur le document/les images imprimés, des erreurs et/ou des omissions ne peuvent pas être exclues en raison des processus de transmission et de conversion de données et des limitations inhérentes aux processus de traduction (éventuellement) automatique utilisés. Les liens hypertexte suivis de ce symbole sont associés à des ressources externes qui ne sont pas contrôlées par l'OMPI. L'OMPI décline toute responsabilité concernant les points mentionnés ci-dessus.

INTERNATIONAL SEARCH REPORT (ISR)
Part 1:  1  2  3  4  5  6          Part 2:  A  B  C  D  E 
International application No. Applicant's or agent's file reference
PCT/EP2020/053000 DH/P20544WO
International filing date (day/month/year) (Earliest) Priority Date (day/month/year)
06 February 2020 07 February 2019
Applicant
NORDIC BIOSCIENCE A/S
FOR FURTHER ACTION: See Form PCT/ISA/220 as well as, where applicable, item 5 below.
This international search report has been prepared by this International Searching Authority and is transmitted to the applicant according to Article 18. A copy is being transmitted to the International Bureau.
It is also accompanied by a copy of each prior art document cited in this report.
1. Basis of the report
a. With regard to the language, the international search was carried out on the basis of:
the international application in the language in which it was filed.
a translation of the international application into                                          which is the language of a translation furnished for the purposes of international search (Rules 12.3(a) and 23.1(b)).
b.
This international search report has been established taking into account the rectification of an obvious mistake authorized by or notified to this Authority under Rule 91 (Rule 43.6bis(a)).
c.
1. With regard to any nucleotide and/or amino acid sequence disclosed in the international application, the international search was carried out on the basis of a sequence listing:
a. forming part of the international application as filed:
in the form of an Annex C/ST.25 text file.
on paper or in the form of an image file.
b. furnished together with the international application under PCT Rule 13ter.1(a) for the purposes of international search only in the form of an Annex C/ST.25 text file.
c. furnished subsequent to the international filing date for the purposes of international search only:
in the form of an Annex C/ST.25 text file (Rule 13ter.1(a)).
on paper or in the form of an image file (Rule 13ter.1(b) and Administrative Instructions, Section 713).
2.
In addition, in the case that more than one version or copy of a sequence listing has been filed or furnished, the required statements that the information in the subsequent or additional copies is identical to that forming part of the application as filed or does not go beyond the application as filed, as appropriate, were furnished.
3.
Additional comments:
2. Certain claims were found unsearchable
3. Unity of invention is lacking
4. Title of the invention
The text is approved as submitted by the applicant.
The text has been established by this Authority to read as follows:
5. Abstract
The text is approved as submitted by the applicant.
The text has been established, according to Rule 38.2, by this Authority as it appears in Box No. IV. The applicant may, within one month from the date of mailing of this international search report, submit comments to this Authority.
6. Drawings
a.
The figure of the drawings to be published with the abstract is Figure No.     2    
as suggested by the applicant.
as selected by this Authority, because the applicant failed to suggest a figure.
as selected by this Authority, because this figure better characterizes the invention.
b.
none of the figures is to be published with the abstract.

A. CLASSIFICATION OF SUBJECT MATTER

     C07K 16/18 (2006.01)i; G01N 33/00 (2006.01)i
According to International Patent Classification (IPC) or to both national classification and IPC

B. FIELDS SEARCHED

Minimum documentation searched (classification system followed by classification symbols):
     C07K; G01N
Documentation searched other than minimum documentation to the extent that such documents are included in the fields searched:
Electronic data base consulted during the international search (name of data base and, where practicable, search terms used):
EPO-Internal, BIOSIS, EMBASE, CHEM ABS Data, WPI Data

C. DOCUMENTS CONSIDERED TO BE RELEVANT

Category* Citation of document, with indication, where appropriate, of the relevant passages Relevant to claim No.
(1)
X
Anonymous, "R&D SYSTEMS: Human Collagen XXIII [alpha]1 Antibody", 02 July 2018 (2018-07-02),
Retrieved from the Internet:
URL:https://resources.rndsystems.com/pdfs/datasheets/mab4165.pdf
XP055693415
[retrieved on  2020-05-11]
1-17,21-26
A
the whole document
18-20
(2)
X
Anonymous, "R&D SYSTEMS Human Collagen XXIII [alpha]1 Antibody Antigen Affinity-purified Polyclonal Sheep IgG Catalog Number: AF4165", 02 June 2018 (2018-06-02),
Retrieved from the Internet:
URL:https://resources.rndsystems.com/pdfs/datasheets/af4165.pdf
XP055693624
[retrieved on  2020-05-11]
1-17,21-26
A
the whole document
18-20
(3)
X
WO 03079884 A2 (CHILDRENS MEDICAL CENTER [US]; ZETTER BRUCE [US] ET AL.) 02 October 2003 (2003-10-02)
1-26
the whole document
see in particular abstract; Fig. 2A, 5-8A, paragr. [0051] to [0055], [00161] to [00163]
(4)
X
JACQUELINE BANYARD ET AL, "Type XXIII Collagen, a New Transmembrane Collagen Identified in Metastatic Tumor Cells", JOURNAL OF BIOLOGICAL CHEMISTRY,Vol. 278, No. 23, 18 March 2003 (2003-03-18), page 20989-20994,
XP055693446
1-26
cited in the application
the whole document
see in particular abstract; Fig. 2-8, page 20992-3
(5)
X
J. BANYARD ET AL, "Collagen XXIII Expression Is Associated with Prostate Cancer Recurrence and Distant Metastases", CLINICAL CANCER RESEARCH,Vol. 13, No. 9, 01 May 2007 (2007-05-01), page 2634-2642,
XP055693689
1-26
cited in the application
the whole document
X
& J Banyard ET AL, "Suppl. Data: Collagen XXIII Expression Is Associated with Prostate Cancer Recurrence and Distant Metastases", 01 May 2017 (2017-05-01),
Retrieved from the Internet:
URL:https://clincancerres.aacrjournals.org/content/clincanres/suppl/2007/05/08/13.9.2634.DC1/Supplementary_Data_Banyard_et_al.pdf
XP055695055
[retrieved on  2020-05-13]
1-26
the whole document
(6)
X
MANUEL KOCH ET AL, "Expression of Type XXIII Collagen mRNA and Protein", JOURNAL OF BIOLOGICAL CHEMISTRY,Vol. 281, No. 30, 25 May 2006 (2006-05-25), page 21546-21557,
XP055693444
1-26
the whole document
see in particular abstract; Fig. 6A-C, page 21551, right-col, 2nd paragr. to page 21552, left-col.
(7)
A
HANCOCK DAVID C ET AL, "Synthetic peptides as antigens for antibody production", ANTIBODY-DRUG CONJUGATES; IN: METHODS IN MOLECULAR BIOLOGY; ISSN 1064-3745; VOL. 1045; [METHODS IN MOLECULAR BIOLOGY; ISSN 1064-3745; VOL. 1045], HUMANA PRESS, US,Vol. 295, 13 December 2004 (2004-12-13), page 13-25,
XP008102135
ISBN: 9781627035415
1-26
the whole document
(8)
A
WO 2019020797 A1 (NORDIC BIOSCIENCE AS [DK]) 31 January 2019 (2019-01-31)
1-26
the whole document
(9)
A
WO 2017129480 A1 (NORDIC BIOSCIENCE AS [DK]) 03 August 2017 (2017-08-03)
1-26
the whole document
(10)
A
WO 2018167111 A1 (NORDIC BIOSCIENCE AS [DK]) 20 September 2018 (2018-09-20)
1-26
the whole document
(11)
A
CHRISTINA JENSEN ET AL, "Serum type XVI collagen is associated with colorectal cancer and ulcerative colitis indicating a pathological role in gastrointestinal disorders", CANCER MEDICINE,Vol. 7, No. 9, 01 September 2018 (2018-09-01), page 4619-4626,
XP055538826
1-26
the whole document
(12)
A
HONGMIN TU ET AL, "Membrane-associated collagens with interrupted triple-helices (MACITs): evolution from a bilaterian common ancestor and functional conservation in C. elegans", BMC EVOLUTIONARY BIOLOGY,Vol. 15, No. 1, 01 December 2015 (2015-12-01),
XP055695230
1-26
the whole document
(13)
X,P
MANON-JENSEN TINA ET AL, "Mo1822 - Elevated Ectodomain of Type 23 Collagen is a Novel Biomarker of the Intestinal Epithelium to Monitor Disease Activity in Ulcerative Colitis and in Crohns Disease", GASTROENTEROLOGY : OFFICIAL PUBLICATION OF THE AMERICAN GASTROENTEROLOGICAL ASSOCIATION,Vol. 156, No. 6, 03 May 2019 (2019-05-03),
XP085679108
1-26
the whole document
*
Special categories of cited documents:
"A"
document defining the general state of the art which is not considered to be of particular relevance
"D"
document cited by the applicant in the international application
"E"
earlier application or patent but published on or after the international filing date
"L"
document which may throw doubts on priority claim(s) or which is cited to establish the publication date of another citation or other special reason (as specified)
"O"
document referring to an oral disclosure, use, exhibition or other means
"P"
document published prior to the international filing date but later than the priority date claimed
"T"
later document published after the international filing date or priority date and not in conflict with the application but cited to understand the principle or theory underlying the invention
"X"
document of particular relevance; the claimed invention cannot be considered novel or cannot be considered to involve an inventive step when the document is taken alone
"Y"
document of particular relevance; the claimed invention cannot be considered to involve an inventive step when the document is combined with one or more other such documents, such combination being obvious to a person skilled in the art
"&"
document member of the same patent family

D. INFORMATION ON PATENT FAMILY MEMBERS

Patent document cited in search report Publication date
(day/month/year)
Patent family member(s) Publication date
(day/month/year)
WO 03079884 A2
02 October 2003
AU 2003218208 A1
US 2006078882 A1
US 2012115134 A1
US 2017184600 A1
WO 03079884 A2
08 October 2003
13 April 2006
10 May 2012
29 June 2017
02 October 2003
WO 2019020797 A1
31 January 2019
EP 3658917 A1
KR 20200032704 A
WO 2019020797 A1
03 June 2020
26 March 2020
31 January 2019
WO 2017129480 A1
03 August 2017
CA 3007582 A1
CN 108602882 A
EP 3408289 A1
JP 2019507731 A
KR 20180102647 A
US 2019195875 A1
WO 2017129480 A1
03 August 2017
28 September 2018
05 December 2018
22 March 2019
17 September 2018
27 June 2019
03 August 2017
WO 2018167111 A1
20 September 2018
EP 3596120 A1
US 2020087385 A1
WO 2018167111 A1
22 January 2020
19 March 2020
20 September 2018
Name and mailing address of the ISA/:
European Patent Office
P.B. 5818, Patentlaan 2, 2280 HV Rijswijk,
Netherlands
Telephone No. (+31-70)340-2040
Facsimile No. (+31-70)340-3016
Date of the actual completion of the international search:
14 May 2020
Date of mailing of the international search report:
26 May 2020
Authorized officer:
Sirim, Pinar
Top    Part 1: 1 2 3 4 5 6         Part 2: A B C D E